Increased expression of cyclooxygenase-1 and -2 in the diabetic rat renal medulla.
暂无分享,去创建一个
[1] K. Nakao,et al. Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist. , 2002, Journal of the American Society of Nephrology : JASN.
[2] T. Tanabe,et al. Prostacyclin-dependent Apoptosis Mediated by PPARδ* , 2001, The Journal of Biological Chemistry.
[3] E. Schulze-Lohoff,et al. Regulation of mesangial cell function by vasodilatory signaling molecules. , 2001, Cardiovascular research.
[4] Rania Nasrallah,et al. Effect of COX-2 inhibitor NS-398 on expression of PGE2 receptor subtypes in M-1 mouse CCD cells. , 2001, American journal of physiology. Renal physiology.
[5] S. Mader,et al. Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. , 2001, The Journal of clinical investigation.
[6] Rania Nasrallah,et al. Molecular and biochemical characterization of prostacyclin receptors in rat kidney. , 2001, American journal of physiology. Renal physiology.
[7] C. Hao,et al. Dehydration activates an NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells. , 2000, The Journal of clinical investigation.
[8] R. Harris,et al. Role of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride. , 2000, The Journal of clinical investigation.
[9] J. Kopple,et al. Protein metabolism in patients with chronic renal failure: role of uremia and dialysis. , 2000, Kidney international.
[10] O. Laneuville,et al. NS-398 upregulates constitutive cyclooxygenase-2 expression in the M-1 cortical collecting duct cell line. , 1999, Journal of the American Society of Nephrology : JASN.
[11] B. Escalante,et al. Effect of cyclooxygenase-2 inhibition on renal function after renal ablation. , 1999, Hypertension.
[12] H. Seyberth,et al. Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney. , 1999, Journal of the American Society of Nephrology : JASN.
[13] S. Narumiya,et al. Roles of prostaglandin E receptors in mesangial cells under high-glucose conditions. , 1999, Kidney international.
[14] M. Burnier,et al. Renal effects of selective cyclooxygenase‐2 inhibition in normotensive salt‐depleted subjects , 1999, Clinical pharmacology and therapeutics.
[15] K. Thai,et al. Effect of glucose on stress-activated protein kinase activity in mesangial cells and diabetic glomeruli. , 1999, Kidney international.
[16] G. Almazan,et al. Localization of Functional Prostaglandin E2 Receptors EP3 and EP4 in the Nuclear Envelope* , 1999, The Journal of Biological Chemistry.
[17] D. Dewitt,et al. Cox-2-selective inhibitors: the new super aspirins. , 1999, Molecular pharmacology.
[18] S. Narumiya,et al. Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.
[19] M. Abramovitz,et al. Nuclear localization of prostaglandin E2 receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[20] R. Hébert,et al. Prostanoid signaling, localization, and expression of IP receptors in rat thick ascending limb cells. , 1998, American journal of physiology. Renal physiology.
[21] B. Koller,et al. Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2. , 1998, American journal of physiology. Renal physiology.
[22] R. Breyer,et al. Regulation of renal function by prostaglandin E receptors. , 1998, Kidney international. Supplement.
[23] R. DuBois,et al. Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells. , 1997, The American journal of physiology.
[24] K Watanabe,et al. Two types of microsomal prostaglandin E synthase: glutathione-dependent and -independent prostaglandin E synthases. , 1997, Biochemical and biophysical research communications.
[25] H. Seyberth,et al. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. , 1997, The American journal of physiology.
[26] L. Ruilope,et al. Effects of cicaprost and fosinopril on the progression of rat diabetic nephropathy. , 1997, American journal of hypertension.
[27] M. Schwartz,et al. Diabetes Complications--Why Is Glucose Potentially Toxic? , 1996, Science.
[28] H. Jacobson,et al. Differential localization of prostaglandin E receptor subtypes in human kidney. , 1996, The American journal of physiology.
[29] J. Pfeilschifter,et al. Effect of cyclic AMP and prostaglandin E2 on the induction of nitric oxide- and prostanoid-forming pathways in cultured rat mesangial cells. , 1996, The Biochemical journal.
[30] R. Langenbach,et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.
[31] Hyung-Suk Kim,et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration , 1995, Cell.
[32] H. Jacobson,et al. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. , 1994, The Journal of clinical investigation.
[33] S. Narumiya,et al. VIII. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes , 1994 .
[34] R. Shigemoto,et al. Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney. , 1994, The American journal of physiology.
[35] F. DeRubertis,et al. Eicosanoids in the pathogenesis of the functional and structural alterations of the kidney in diabetes. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[36] J. Manivel,et al. Prostaglandins protect kidneys against ischemic and toxic injury by a cellular effect. , 1992, Kidney international.
[37] W. K. Sonnenburg,et al. A prostaglandin E receptor coupled to a pertussis toxin-sensitive guanine nucleotide regulatory protein in rabbit cortical collecting tubule cells. , 1990, The Journal of biological chemistry.
[38] G. Remuzzi,et al. Glomerular Hyperfiltration and Urinary Prostaglandins in Type 1 Diabetes Mellitus , 1989, Diabetic medicine : a journal of the British Diabetic Association.
[39] F. Pugliese,et al. Renal Hemodynamics and Urinary Excretion of 6-Keto-Prostaglandin F1α and Thromboxane B2 in Newly Diagnosed Type I Diabetic Patients , 1988, Diabetes.
[40] N. Farman,et al. Segmental synthesis and actions of prostaglandins along the nephron. , 1987, The American journal of physiology.
[41] M. Schambelan,et al. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. , 1985, The Journal of clinical investigation.
[42] J. Kreisberg,et al. The effects of insulin, glucose and diabetes on prostaglandin production by rat kidney glomeruli and cultured glomerular mesangial cells. , 1983, Prostaglandins, leukotrienes, and medicine.
[43] M. Dunn,et al. Prostaglandin synthesis by rat glomerular mesangial cells in culture. Effects of angiotensin II and arginine vasopressin. , 1983, The Journal of clinical investigation.
[44] W. Smith,et al. Immunohistochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex. , 1978, The American journal of physiology.
[45] V. Devita,et al. Clinical antitumor activity and toxicity of streptozotocin (NSC‐85998) , 1974, Cancer.
[46] D. Dewitt,et al. Prostaglandin endoperoxide H synthases-1 and -2. , 1996, Advances in immunology.
[47] H. Schramek,et al. ET‐1 and PDGF BB Induce MEK mRNA and Protein Expression in Mesangial Cells , 1995, Journal of cardiovascular pharmacology.
[48] T. Ogihara,et al. Effects of beraprost sodium, a stable analogue of prostacyclin, on hyperplasia, hypertrophy and glycosaminoglycan synthesis of rat aortic smooth muscle cells. , 1993, Artery.